Micro-anatomy related antigen expression in melanocytic lesions
- PMID: 10727983
- DOI: 10.1002/(SICI)1096-9896(200004)190:5<572::AID-PATH570>3.0.CO;2-9
Micro-anatomy related antigen expression in melanocytic lesions
Abstract
The in situ expression of antigens associated with melanosomes (gp-100), pigmentation (PAA), tyrosinase (TRP-1), melanoma (MAA-1/MAA-2), and HLA-DR was investigated immunohistochemically in frozen archival specimens of common acquired melanocytic naevi, in dysplastic melanocytic naevi, and in lymph node metastases of melanoma. Expression of these antigens was also studied in established cultured normal human melanocytes, naevus-derived melanocytes and melanoma cell lines of varying metastatic potential, by immunohistochemistry and flow cytometry. Compared with normal melanocytes, melanocytic naevi exhibited increased expression of gp-100, PAA, and TRP-1 in the lesional cells at or very near the dermo-epidermal junction, but with diminishing expression towards the intra-dermal base of the lesions. In contrast, expression of MAA-1 and MAA-2 was observed in melanocytes throughout the dermal part of the naevi. Melanocytes located at the basal layer of the epidermis were positive only for gp-100, PAA, and TRP-1 antigens. Dysplastic melanocytic naevi showed staining of gp-100, PAA, TRP-1, HLA-DR, MAA-1, and MAA-2 of junctional lesional melanocytes, but less intense than that of common acquired naevi. These antigens were not detectable in the dermal part of the dysplastic naevi. Expression of these antigens in lymph node metastases of melanoma was either positive or negative. Similar results regarding antigen expression were observed in all cultured melanocytic cells, both by immunohistochemistry and by flow cytometry. The present data suggest that analysis of these antigens may contribute to the discrimination of common acquired melanocytic naevi from their dysplastic counterparts. Furthermore, variations in the levels of expression in naevi may be consistently related to the micro-anatomy of the lesions, indicating that the micro-environment may have an influence on the expression levels of these antigens in different lesional melanocytes.
Copyright 2000 John Wiley & Sons, Ltd.
Similar articles
-
Expression patterns of S100 proteins in melanocytes and melanocytic lesions.Melanoma Res. 2009 Aug;19(4):215-25. doi: 10.1097/CMR.0b013e32832c6358. Melanoma Res. 2009. PMID: 19521263
-
The initial steps of tumor progression in melanocytic lineage: a histochemical approach.Anticancer Res. 1991 Jul-Aug;11(4):1405-14. Anticancer Res. 1991. PMID: 1746897
-
Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.Melanoma Res. 2008 Jun;18(3):166-71. doi: 10.1097/CMR.0b013e3282fe9a16. Melanoma Res. 2008. PMID: 18477890
-
The approach to the patient with a difficult melanocytic lesion.Pathology. 2004 Oct;36(5):428-34. doi: 10.1080/00313020412331283905. Pathology. 2004. PMID: 15370112 Review.
-
[Melanocytic nevi].Rev Prat. 1999 Apr 15;49(8):829-32. Rev Prat. 1999. PMID: 10337194 Review. French.
Cited by
-
Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells.Am J Pathol. 2002 Feb;160(2):521-8. doi: 10.1016/s0002-9440(10)64871-7. Am J Pathol. 2002. PMID: 11839572 Free PMC article.
-
Transfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategy.J Autoimmune Dis. 2005 Aug 31;2:7. doi: 10.1186/1740-2557-2-7. J Autoimmune Dis. 2005. PMID: 16135249 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials